Inventor

ANDREWS STEVEN W

US88 patents

⚠️ This page may combine multiple inventors who share the name “ANDREWS STEVEN W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ANDREWS STEVEN W

ARRAY BIOPHARMA INC

Macrocyclic compounds as trk kinase inhibitors

Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds

2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Macrocyclic compounds as TRK kinase inhibitors

Macrocyclic compounds as TRK kinase inhibitors

Macrocyclic compounds as Trk kinase inhibitors

Macrocyclic compounds as Trk kinase inhibitors

Method of treatment using substituted pyrazolo[1,5-A] pyrimidine compounds

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds

Method of treatment using substituted imidazo[1,2b]pyridazine compounds

Method of treatment using substituted imidazo[1,2b]pyridazine compounds

Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors

Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Macrocyclic compounds as TRK kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Method of treatment using substituted imidazo[1,2b]pyridazine compounds

ALLERGAN INC

Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

3-(Arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors

3-(heteroarylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors

3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors

Kinase inhibitors for the treatment of disease

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Cyclopentane heptanoic or heptenoic acid, 2-arylalkyl or arylalkenyl and derivatives as therapeutic agents

(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors

3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors

Kinase inhibitors for the treatment of disease

ALLERGAN SALES INC

Non-acidic cyclopentane heptanoic acid,2-cycloalkyl or arylalkyl derivatives as therapeutic agents

Cyclopentane (ene) oic acid, 2-alkenyl derivatives as therapeutic agents

Ocular hypotensive lipids

INTERMUNE INC

Macrocyclic compounds as inhibitors of viral replication

Macrocyclic inhibitors of hepatitis C virus replication

HAAS JULIA

Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors

BLATT LAWRENCE M

Macrocyclic inhibitors of hepatitis C virus replication

ALLERGAN SALES LLC

(3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors

ANDREWS STEVEN W

Method of treatment using substituted imidazo[1,2B]pyridazine compounds